Suppr超能文献

椎间盘退变的生物治疗策略:潜力与不足

Biological treatment strategies for disc degeneration: potentials and shortcomings.

作者信息

Paesold Günther, Nerlich Andreas G, Boos Norbert

机构信息

Centre for Spinal Surgery, University of Zürich, Balgrist, Zurich, Switzerland.

出版信息

Eur Spine J. 2007 Apr;16(4):447-68. doi: 10.1007/s00586-006-0220-y. Epub 2006 Sep 16.

Abstract

Recent advances in molecular biology, cell biology and material sciences have opened a new emerging field of techniques for the treatment of musculoskeletal disorders. These new treatment modalities aim for biological repair of the affected tissues by introducing cell-based tissue replacements, genetic modifications of resident cells or a combination thereof. So far, these techniques have been successfully applied to various tissues such as bone and cartilage. However, application of these treatment modalities to cure intervertebral disc degeneration is in its very early stages and mostly limited to experimental studies in vitro or in animal studies. We will discuss the potential and possible shortcomings of current approaches to biologically cure disc degeneration by gene therapy or tissue engineering. Despite the increasing number of studies examining the therapeutic potential of biological treatment strategies, a practicable solution to routinely cure disc degeneration might not be available in the near future. However, knowledge gained from these attempts might be applied in a foreseeable future to cure the low back pain that often accompanies disc degeneration and therefore be beneficial for the patient.

摘要

分子生物学、细胞生物学和材料科学的最新进展开启了一个用于治疗肌肉骨骼疾病的新兴技术领域。这些新的治疗方式旨在通过引入基于细胞的组织替代物、对驻留细胞进行基因改造或二者结合来对受影响组织进行生物修复。到目前为止,这些技术已成功应用于各种组织,如骨骼和软骨。然而,将这些治疗方式应用于治疗椎间盘退变尚处于非常早期的阶段,且大多局限于体外实验研究或动物研究。我们将讨论当前通过基因治疗或组织工程对椎间盘退变进行生物治疗方法的潜力和可能存在的不足。尽管研究生物治疗策略治疗潜力的研究数量不断增加,但在不久的将来可能仍无法获得常规治愈椎间盘退变的可行解决方案。然而,从这些尝试中获得的知识可能会在可预见的未来应用于治疗常伴随椎间盘退变的腰痛,从而使患者受益。

相似文献

1
Biological treatment strategies for disc degeneration: potentials and shortcomings.
Eur Spine J. 2007 Apr;16(4):447-68. doi: 10.1007/s00586-006-0220-y. Epub 2006 Sep 16.
2
Tissue engineering and the intervertebral disc: the challenges.
Eur Spine J. 2008 Dec;17 Suppl 4(Suppl 4):480-91. doi: 10.1007/s00586-008-0746-2. Epub 2008 Nov 13.
3
Future perspectives of cell-based therapy for intervertebral disc disease.
Eur Spine J. 2008 Dec;17 Suppl 4(Suppl 4):452-8. doi: 10.1007/s00586-008-0743-5. Epub 2008 Nov 13.
4
Biologic strategies for the therapy of intervertebral disc degeneration.
Expert Opin Biol Ther. 2003 Dec;3(8):1209-14. doi: 10.1517/14712598.3.8.1209.
5
Current Treatment Options for Intervertebral Disc Pathologies.
Cartilage. 2020 Apr;11(2):143-151. doi: 10.1177/1947603520907665. Epub 2020 Feb 19.
6
Current developments in tissue engineering of nucleus pulposus for the treatment of intervertebral disc degeneration.
Annu Int Conf IEEE Eng Med Biol Soc. 2007;2007:6401-6. doi: 10.1109/IEMBS.2007.4353821.
7
Regeneration of intervertebral disc by mesenchymal stem cells: potentials, limitations, and future direction.
Eur Spine J. 2006 Aug;15 Suppl 3(Suppl 3):S406-13. doi: 10.1007/s00586-006-0183-z. Epub 2006 Jul 15.
8
Regenerative treatment strategies in spinal surgery.
Front Biosci. 2008 Jan 1;13:1507-25. doi: 10.2741/2777.
9
Recent advances in disc cell biology.
Spine (Phila Pa 1976). 2003 Jan 15;28(2):186-93. doi: 10.1097/00007632-200301150-00017.

引用本文的文献

5
New Hope for Treating Intervertebral Disc Degeneration: Microsphere-Based Delivery System.
Front Bioeng Biotechnol. 2022 Jul 19;10:933901. doi: 10.3389/fbioe.2022.933901. eCollection 2022.
8
Cervical spinal instability causes vertebral microarchitecture change and vertebral endplate lesion in rats.
J Orthop Translat. 2019 Nov 6;24:209-217. doi: 10.1016/j.jot.2019.10.005. eCollection 2020 Sep.
10
[Research progress on the role of adipokines in intervertebral disc degeneration].
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2020 Mar 15;34(3):399-403. doi: 10.7507/1002-1892.201906004.

本文引用的文献

1
Biologic response of human intervertebral disc cells to gene therapy cocktail.
Spine (Phila Pa 1976). 2008 Aug 1;33(17):1850-5. doi: 10.1097/BRS.0b013e31817e1cd7.
2
Temporo-spatial distribution of blood vessels in human lumbar intervertebral discs.
Eur Spine J. 2007 Apr;16(4):547-55. doi: 10.1007/s00586-006-0213-x. Epub 2006 Sep 1.
3
Interaction of human mesenchymal stem cells with disc cells: changes in extracellular matrix biosynthesis.
Spine (Phila Pa 1976). 2006 Aug 15;31(18):2036-42. doi: 10.1097/01.brs.0000231442.05245.87.
4
The TRP2 allele of COL9A2 is an age-dependent risk factor for the development and severity of intervertebral disc degeneration.
Spine (Phila Pa 1976). 2005 Dec 15;30(24):2735-42. doi: 10.1097/01.brs.0000190828.85331.ef.
6
Intervertebral disc cell-mediated mesenchymal stem cell differentiation.
Stem Cells. 2006 Mar;24(3):707-16. doi: 10.1634/stemcells.2005-0205. Epub 2005 Oct 13.
8
Regenerative effects of transplanting mesenchymal stem cells embedded in atelocollagen to the degenerated intervertebral disc.
Biomaterials. 2006 Jan;27(3):335-45. doi: 10.1016/j.biomaterials.2005.06.038. Epub 2005 Aug 19.
9
The role of interleukin-1 in the pathogenesis of human intervertebral disc degeneration.
Arthritis Res Ther. 2005;7(4):R732-45. doi: 10.1186/ar1732. Epub 2005 Apr 1.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验